People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocean Biomedical, Inc. | — | Biotechnology | Series A | $8.6M | $67.6M | 2023 |
Suren A. Ajjarapu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Suren A. Ajjarapu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William A Owens | 1 | 6 |
| Daniel Behr | 1 | 4 |
| MICHAEL A PETERSON | 1 | 3 |
| Robert Sweeney | 1 | 2 |
| Jonathan Heller | 1 | 2 |
| Jonathan A. Kurtis | 1 | 1 |
| Martin D. Angle | 1 | 1 |
| Inderjote Kathuria | 1 | 1 |
| Michelle D. Berrey | 1 | 1 |
| Jerome A. Ringo | 1 | 1 |
| Chirinjeev Kathuria, | 1 | 1 |
| Elizabeth Ng | 1 | 1 |
| Gurinder Kalra | 1 | 1 |
| Jack A. Elias | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.